Checking for rheumatoid arthritis involves a combination of physical examination, blood tests, and imaging. No single test confirms or rules it out on its own. Doctors look at the full picture: which joints are affected, how long symptoms have lasted, what shows up in your blood, and what your joints look like on scans. Getting checked early matters because starting treatment within the first three months of symptoms significantly improves long-term outcomes.
Symptoms That Prompt Testing
The earliest signs of rheumatoid arthritis tend to show up in the small joints of your hands, wrists, and feet. Unlike osteoarthritis, which typically hits weight-bearing joints like knees and hips and often affects one side more than the other, RA is symmetrical. If the knuckles on your left hand are swollen, the same knuckles on your right hand usually are too.
Morning stiffness is one of the most telling symptoms. Everyone feels a little stiff when they wake up, but with RA, that stiffness lasts more than an hour and gradually loosens with movement. Osteoarthritis stiffness, by contrast, tends to be shorter and worsens with use throughout the day. Another distinguishing feature: osteoarthritis often produces hard, bony bumps on the finger joints closest to the nails, while RA causes soft, puffy swelling around the knuckles closer to the hand.
If you’re experiencing joint pain and swelling in multiple joints, especially small ones on both sides of your body, that pattern alone is enough reason to get evaluated.
What Happens During the Physical Exam
A rheumatologist will squeeze and press on your joints to check for swelling and tenderness. They typically assess 28 joints, including the knuckles, wrists, elbows, shoulders, and knees. They’re looking for two things: joints that are physically swollen (puffy, warm, or visibly enlarged) and joints that hurt when pressed. The number of swollen and tender joints, along with their location, feeds directly into the diagnostic criteria for RA.
The exam also checks your range of motion, grip strength, and whether the swelling feels “boggy” or spongy, which suggests inflamed joint lining rather than bony changes. Your doctor will ask how long symptoms have persisted and whether they’ve lasted longer than six weeks, since that duration is one of the formal classification benchmarks.
Blood Tests Used in Diagnosis
Two antibody tests form the core of RA blood work: rheumatoid factor (RF) and anti-CCP antibodies.
Rheumatoid factor was the original blood marker for RA, but it’s not perfectly reliable. RF can show up in people with other autoimmune conditions or even in healthy individuals. Some people with confirmed RA have little to no RF in their blood, particularly early in the disease. That’s why doctors now pair it with the anti-CCP test. Anti-CCP antibodies are found in most people with RA and are almost never found in people without it, making this test far more specific.
The combination of both tests gives the clearest picture:
- Both positive: Strong indication of RA
- Anti-CCP positive, RF negative: May indicate early-stage RA or future development of the disease
- Both negative: RA is less likely, though not ruled out
Your doctor will also order tests that measure general inflammation in your body. The two most common are ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein). Normal ESR falls roughly in the range of 0 to 10 mm/hour, though the upper limit increases with age. Normal CRP is below 5 mg/L. Elevated levels of either suggest active inflammation somewhere in the body. These markers aren’t specific to RA, but when combined with antibody results and joint symptoms, they help confirm the diagnosis and gauge how active the disease is.
When Blood Tests Come Back Normal
Between 15% and 25% of people with RA test negative for both RF and anti-CCP antibodies. This is called seronegative RA, and it’s more common than many people realize. During the early stages of the disease, 30% to 45% of patients have negative RF results.
A negative blood test does not mean you don’t have RA. If your symptoms and physical exam point toward the disease, your doctor can still make the diagnosis based on clinical judgment, imaging findings, and the overall pattern of joint involvement. In seronegative cases, additional biomarkers like antikeratin antibodies may be tested when available. Imaging becomes especially important for these patients, since it can reveal joint inflammation and damage that blood work misses entirely.
Imaging: X-Rays, Ultrasound, and MRI
Standard X-rays are often the first imaging step, but they have a significant limitation: they mainly show bone damage that’s already happened. In early RA, joints can be actively inflamed for months before anything abnormal appears on an X-ray.
Ultrasound and MRI are far better at catching the disease early. Both can detect inflammation of the joint lining, tendons, and surrounding tissue with greater sensitivity than a physical exam alone. In patients with RA lasting less than six months, MRI identifies bone erosions in 45% to 72% of cases, compared with just 8% to 40% for X-rays. MRI has an additional advantage: it can detect bone marrow swelling, which is considered a precursor to erosions and a marker of active inflammation. No other imaging method can see this.
Ultrasound is more accessible and less expensive than MRI, and it’s useful for confirming inflammation in specific joints during an office visit. However, it can’t visualize all erosions due to limitations in probe positioning. MRI is currently considered the best noninvasive imaging tool for evaluating joint inflammation, tendon involvement, and early bone changes.
How Doctors Put It All Together
Rheumatologists use a standardized classification system that assigns points across four categories: the number and type of joints involved, antibody results (RF and anti-CCP), how long symptoms have lasted (under or over six weeks), and whether inflammation markers (ESR and CRP) are elevated. A score of 6 or higher out of 10 points classifies a patient as having RA.
This scoring system works well for most patients, but it can miss seronegative cases. That’s where clinical experience fills the gap. A rheumatologist who sees the right symptom pattern, the right physical exam findings, and the right imaging results can diagnose RA even when the point score falls short.
Why Early Testing Changes Outcomes
RA causes the most joint damage in its first two years. Research consistently shows that starting treatment within 12 weeks of symptom onset, often called the “window of opportunity,” leads to better chances of remission and less irreversible joint damage. The longer the disease goes untreated, the harder it becomes to control.
If you’ve had joint swelling, morning stiffness lasting over an hour, or pain in matching joints on both sides of your body for more than a few weeks, getting a rheumatology evaluation sooner rather than later gives you the best chance of preserving joint function long term. RA can also affect organs beyond the joints, including the eyes, heart, and lungs, which makes early identification even more consequential.